AI assistant
Sending…
Korro Bio, Inc. — Director's Dealing 2025
Apr 2, 2025
33032_dirs_2025-04-01_fb075756-5d18-4162-800f-c73f48ea9ee8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2025-04-01
Reporting Person: Vincent Loic A (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-01 | Stock Option (Right to Buy) | $15.95 | A | 70000 | Acquired | 2035-03-30 | Common Stock (70000) | Direct |
Footnotes
F1: The shares subject to the option vest as to 25% of the shares on March 31, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date
More from Korro Bio, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Regulatory Filings
2026
Mar 23
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17